The physics, biophysics and technology of photodynamic therapy

Photodynamic therapy (PDT) uses light-activated drugs to treat diseases ranging from cancer to age-related macular degeneration and antibiotic-resistant infections. This paper reviews the current status of PDT with an emphasis on the contributions of physics, biophysics and technology, and the challenges remaining in the optimization and adoption of this treatment modality. A theme of the review is the complexity of PDT dosimetry due to the dynamic nature of the three essential components -- light, photosensitizer and oxygen. Considerable progress has been made in understanding the problem and in developing instruments to measure all three, so that optimization of individual PDT treatments is becoming a feasible target. The final section of the review introduces some new frontiers of research including low dose rate (metronomic) PDT, two-photon PDT, activatable PDT molecular beacons and nanoparticle-based PDT.

[1]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[2]  J E Kaufman,et al.  Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.

[3]  T J Dougherty,et al.  Photoradiation in the treatment of recurrent breast carcinoma. , 1979, Journal of the National Cancer Institute.

[4]  Oxygen dependency of photocytotoxicity with haematoporphyrin derivative. , 1984, Photochemistry and photobiology.

[5]  W. H. Betts,et al.  OXYGEN DEPENDENCY OF PHOTOCYTOTOXICITY WITH HAEMATOPORPHYRIN DERIVATIVE , 1984 .

[6]  B. C. Wilson,et al.  Studies of HPD and radiolabelled HPD in-vivo and in-vitro. , 1985, Advances in experimental medicine and biology.

[7]  J Moan,et al.  Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. , 1985, Cancer research.

[8]  M S Patterson,et al.  The physics of photodynamic therapy. , 1986, Physics in medicine and biology.

[9]  M S Patterson,et al.  Total attenuation coefficients and scattering phase functions of tissues and phantom materials at 633 nm. , 1987, Medical physics.

[10]  H. Barr,et al.  THE CONTRASTING MECHANISMS OF COLONIC COLLAGEN DAMAGE BETWEEN PHOTODYNAMIC THERAPY and THERMAL INJURY , 1987, Photochemistry and photobiology.

[11]  M. Keijzer,et al.  LIGHT DOSIMETRY FOR PHOTODYNAMIC THERAPY BY WHOLE BLADDER WALL IRRADIATION , 1987, Photochemistry and photobiology.

[12]  M. Rodgers.  On the problems involved in detecting luminescence from singlet oxygen in biological specimens. , 1988, Journal of photochemistry and photobiology. B, Biology.

[13]  S. Arridge,et al.  Estimation of optical pathlength through tissue from direct time of flight measurement , 1988 .

[14]  B. Wilson,et al.  Radiolabelled photosensitizers for tumour imaging and photodynamic therapy. , 1989, Journal of photochemistry and photobiology. B, Biology.

[15]  M S Patterson,et al.  Optical properties of normal and diseased human breast tissues in the visible and near infrared. , 1990, Physics in medicine and biology.

[16]  M S Patterson,et al.  In vivo TESTS OF THE CONCEPT OF PHOTODYNAMIC THRESHOLD DOSE IN NORMAL RAT LIVER PHOTOSENSITIZED BY ALUMINUM CHLOROSULPHONATED PHTHALOCYANINE , 1990, Photochemistry and photobiology.

[17]  M S Patterson,et al.  Experimental tests of the feasibility of singlet oxygen luminescence monitoring in vivo during photodynamic therapy. , 1990, Journal of photochemistry and photobiology. B, Biology.

[18]  B. Tromberg,et al.  In vivo TUMOR OXYGEN TENSION MEASUREMENTS FOR THE EVALUATION OF THE EFFICIENCY OF PHOTODYNAMIC THERAPY , 1990, Photochemistry and photobiology.

[19]  A. Welch,et al.  A review of the optical properties of biological tissues , 1990 .

[20]  H. J. van Staveren,et al.  Light scattering in Intralipid-10% in the wavelength range of 400-1100 nm. , 1991, Applied optics.

[21]  H Key,et al.  Optical attenuation characteristics of breast tissues at visible and near-infrared wavelengths. , 1991, Physics in medicine and biology.

[22]  T. Foster,et al.  Oxygen consumption and diffusion effects in photodynamic therapy. , 1991, Radiation research.

[23]  C. Foote.  DEFINITION OF TYPE I and TYPE II PHOTOSENSITIZED OXIDATION , 1991, Photochemistry and photobiology.

[24]  M. Arnfield,et al.  Non-invasive monitoring of photodynamic therapy with 99technetium HMPAO scintigraphy. , 1992, British Journal of Cancer.

[25]  T. Foster,et al.  Dosimetry in photodynamic therapy: oxygen and the critical importance of capillary density. , 1992, Radiation research.

[26]  M. Rodgers,et al.  Current perspectives of singlet oxygen detection in biological environments. , 1992, Journal of photochemistry and photobiology. B, Biology.

[27]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[28]  J. Pickering,et al.  Double-integrating-sphere system for measuring the optical properties of tissue. , 1993, Applied optics.

[29]  D T Delpy,et al.  Measurement of the optical properties of the skull in the wavelength range 650-950 nm , 1993, Physics in medicine and biology.

[30]  M. Schweiger,et al.  A finite element approach for modeling photon transport in tissue. , 1993, Medical physics.

[31]  T. Dougherty.  Photodynamic therapy. , 1993, Photochemistry and photobiology.

[32]  Rick E. Sneed,et al.  Comparative study between pulsed and continuous wave lasers for Photofrin® photodynamic therapy , 1993, Lasers in surgery and medicine.

[33]  Brian C. Wilson,et al.  Charge-coupled device and neural-network-based instrument for the noninvasive determination of tissue optical properties in vivo , 1994, Photonics West - Lasers and Applications in Science and Engineering.

[34]  C J Gomer,et al.  Photodynamic therapy mediated induction of early response genes. , 1994, Cancer research.

[35]  W. Mcgimpsey,et al.  AN EFFICIENT OXYGEN INDEPENDENT TWO‐PHOTON PHOTOSENSITIZATION MECHANISM , 1994, Photochemistry and photobiology.

[36]  L Wang,et al.  MCML--Monte Carlo modeling of light transport in multi-layered tissues. , 1995, Computer methods and programs in biomedicine.

[37]  Hubert van den Bergh,et al.  In-vivo measurement of fluorescence bleaching of meso-tetra hydroxy phenyl chlorin (mTHPC) in the esophagus and the oral cavity , 1995, European Conference on Biomedical Optics.

[38]  R. Veenhuizen,et al.  The importance of fluence rate in photodynamic therapy: is there a parallel with ionizing radiation dose-rate effects? , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  F. Hetzel,et al.  Tumor Oxygenation Changes Post‐Photodynamic Therapy , 1996, Photochemistry and photobiology.

[40]  W. Star,et al.  Calibration of isotropic light dosimetry probes based on scattering bulbs in clear media. , 1996, Physics in medicine and biology.

[41]  H J Sterenborg,et al.  Photodynamic therapy with pulsed light sources: a theoretical analysis , 1996, Physics in medicine and biology.

[42]  C. Gomer,et al.  Cellular targets and molecular responses associated with photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[43]  K. Svanberg,et al.  Superficial blood flow following photodynamic therapy of malignant non–melanoma skin tumours measured by laser Doppler perfusion imaging , 1997, The British journal of dermatology.

[44]  J W Pickering,et al.  In vitro double-integrating-sphere optical properties of tissues between 630 and 1064 nm , 1997, Physics in medicine and biology.

[45]  R. Fournier,et al.  Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy. , 1997, Radiation research.

[46]  R. Weersink,et al.  Accuracy of Noninvasive in vivo Measurements of Photosensitizer Uptake Based on a Diffusion Model of Reflectance Spectroscopy , 1997, Photochemistry and photobiology.

[47]  B W Pogue,et al.  Fiber-optic bundle design for quantitative fluorescence measurement from tissue. , 1998, Applied optics.

[48]  J. Schmitt,et al.  Optical scattering properties of soft tissue: a discrete particle model. , 1998, Applied optics.

[49]  Inactivation of pathogens in blood and blood products. , 1998, Medicine and health, Rhode Island.

[50]  M. Kohl,et al.  Near-infrared optical properties of ex vivo human skin and subcutaneous tissues measured using the Monte Carlo inversion technique. , 1998, Physics in medicine and biology.

[51]  M. Patterson,et al.  Accuracy of the diffusion approximation in determining the optical properties of a two-layer turbid medium. , 1998, Applied optics.

[52]  S. Jacques,et al.  Light Distributions from Point, Line and Plane Sources for Photochemical Reactions and Fluorescence in Turbid Biological Tissues , 1998, Photochemistry and photobiology.

[53]  B. Wilson,et al.  Comparison of the In Vivo Photodynamic Threshold Dose for Photofrin, Mono‐ and Tetrasulfonated Aluminum Phthalocyanine Using a Rat Liver Model , 1998, Photochemistry and photobiology.

[54]  U. Nseyo,et al.  Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience. , 1998, Journal of clinical laser medicine & surgery.

[55]  N. Oleinick,et al.  The photobiology of photodynamic therapy: cellular targets and mechanisms. , 1998, Radiation research.

[56]  Zhongping Chen,et al.  Optical Doppler Tomography: Imaging in vivo Blood Flow Dynamics Following Pharmacological Intervention and Photodynamic Therapy , 1998, Photochemistry and photobiology.

[57]  Stanley B. Brown,et al.  Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.

[58]  R. Redmond,et al.  A Compilation of Singlet Oxygen Yields from Biologically Relevant Molecules , 1999, Photochemistry and photobiology.

[59]  J W Hunt,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1999.0724 Ultrasound imaging of apoptosis: high-resolution noninvasive , 2022 .

[60]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[61]  Michele T. Cooper,et al.  Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. , 2000, Cancer research.

[62]  Simon R. Arridge,et al.  A method for three-dimensional time-resolved optical tomography , 2000, Int. J. Imaging Syst. Technol..

[63]  L. Lilge,et al.  Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue , 2000, British Journal of Cancer.

[64]  E. Hull,et al.  An evaluation of near infrared spectroscopy and cryospectrophotometry estimates of haemoglobin oxygen saturation in a rodent mammary tumour model. , 2000, Physics in medicine and biology.

[65]  Simon R. Arridge,et al.  A method for three‐dimensional time‐resolved optical tomography , 2000 .

[66]  Eiji Kohno,et al.  Detection of Near Infrared Emission from Singlet Oxygen in PDT with an Experimental Tumor Bearing Mouse , 2001 .

[67]  K D Paulsen,et al.  Three-dimensional simulation of near-infrared diffusion in tissue: boundary condition and geometry analysis for finite-element image reconstruction. , 2001, Applied optics.

[68]  S. Mohanty,et al.  Measurement of optical transport properties of normal and malignant human breast tissue. , 2001, Applied optics.

[69]  B. Wilson,et al.  Monitoring of cell and tissue responses to photodynamic therapy by electrical impedance spectroscopy. , 2001, Physics in medicine and biology.

[70]  C. MacAulay,et al.  Monitoring Photoproduct Formation and Photobleaching by Fluorescence Spectroscopy Has the Potential to Improve PDT Dosimetry with a Verteporfin-like Photosensitizer¶ , 2002, Photochemistry and photobiology.

[71]  W. Cheong,et al.  Photodynamic therapy: Applications in atherosclerotic vascular disease with motexafin lutetium , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[72]  M. Krouse,et al.  New Technology for Deep Light Distribution in Tissue for Phototherapy , 2002, Cancer Journal.

[73]  Michael S Patterson,et al.  Direct Near-infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells In Vitro and Tissues In Vivo¶ , 2002, Photochemistry and photobiology.

[74]  Rotterdam,et al.  Performance of isotropic light dosimetry probes based on scattering bulbs in turbid media , 2002 .

[75]  H. Moseley,et al.  Laser and Non-laser Light Sources for Photodynamic Therapy , 2002, Lasers in Medical Science.

[76]  T. Foster,et al.  Effect of Irradiation Fluence Rate on the Efficacy of Photodynamic Therapy and Tumor Oxygenation in Meta-Tetra (Hydroxyphenyl) Chlorin (mTHPC)-Sensitized HT29 Xenografts in Nude Mice1 , 2002, Radiation research.

[77]  Zheng Huang,et al.  Improvement of Tumor Response by Manipulation of Tumor Oxygenation During Photodynamic Therapy¶ , 2002, Photochemistry and photobiology.

[78]  B. Pogue,et al.  Photodynamic Therapy Dosimetry , 2003 .

[79]  Qian Peng,et al.  An outline of the hundred-year history of PDT. , 2003, Anticancer research.

[80]  Michael S Patterson,et al.  Quantification of fluorophore concentration in tissue-simulating media by fluorescence measurements with a single optical fiber. , 2003, Applied optics.

[81]  Michael S Patterson,et al.  In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. , 2003, Cancer research.

[82]  Megan T Valentine,et al.  Microscopic origin of light scattering in tissue. , 2003, Applied optics.

[83]  Michal Neeman,et al.  Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI , 2003, Nature Medicine.

[84]  P. Vaupel,et al.  Tumour tissue monitoring during photodynamic and hyperthermic treatment using bioimpedance spectroscopy. , 2003, Physiological measurement.

[85]  Michael S Patterson,et al.  Measurement of fluorophore concentrations and fluorescence quantum yield in tissue-simulating phantoms using three diffusion models of steady-state spatially resolved fluorescence. , 2003, Physics in medicine and biology.

[86]  T. Foster,et al.  Activation of Heat Shock Protein 70 Promoter with meso-Tetrahydroxyphenyl Chlorin Photodynamic Therapy Reported by Green Fluorescent Protein In Vitro and In Vivo¶ , 2003 .

[87]  Reynée W. Sampson,et al.  Crystal violet combined with Merocyanine 540 for the ex vivo purging of hematopoietic stem cell grafts. , 2003, Journal of photochemistry and photobiology. B, Biology.

[88]  Michael R Hamblin,et al.  Photodynamic Therapy Targeted to Pathogens , 2004, International journal of immunopathology and pharmacology.

[89]  Barbara W. Henderson,et al.  Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors , 2004, Cancer Research.

[90]  Ying Luo,et al.  A photolabile hydrogel for guided three-dimensional cell growth and migration , 2004, Nature materials.

[91]  Britton Chance,et al.  Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. , 2004, Journal of the American Chemical Society.

[92]  Vadim A. Markel.  Modified spherical harmonics method for solving the radiative transport equation , 2004 .

[93]  S. Maier,et al.  High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. , 2004, Radiology.

[94]  S. Bisland.  Metronomic Photodynamic Therapy: Principle to Practice , 2004 .

[95]  Lothar Lilge,et al.  Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶ , 2004, Photochemistry and photobiology.

[96]  L. Kunz,et al.  Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver , 2004, British Journal of Cancer.

[97]  B. Pogue,et al.  Assessment of Photosensitizer Dosimetry and Tissue Damage Assay for Photodynamic Therapy in Advanced-stage Tumors¶ , 2004 .

[98]  Dmitri B Papkovsky,et al.  Methods in optical oxygen sensing: protocols and critical analyses. , 2004, Methods in enzymology.

[99]  Brian Wilson,et al.  Photodynamic therapy for the treatment of metastatic lesions in bone: studies in rat and porcine models , 2004, SPIE BiOS.

[100]  Stanley B. Brown,et al.  Photosensitized inactivation of microorganisms , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[101]  Jarod C Finlay,et al.  Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms. , 2004, Physics in medicine and biology.

[102]  Jarod C Finlay,et al.  Hemoglobin oxygen saturations in phantoms and in vivo from measurements of steady-state diffuse reflectance at a single, short source-detector separation. , 2004, Medical physics.

[103]  Michael T. Wilson.  Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infections , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[104]  I. Tan,et al.  mTHPC‐mediated photodynamic therapy for early oral squamous cell carcinoma , 2004, International journal of cancer.

[105]  Henry Hirschberg,et al.  An Indwelling Brachytherapy Balloon Catheter: Potential Use as an Intracranial Light Applicator for Photodynamic Therapy , 1999, Journal of Neuro-Oncology.

[106]  D. Buerk.  Measuring tissue PO2 with microelectrodes. , 2004, Methods in enzymology.

[107]  Stanley B. Brown,et al.  The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.

[108]  J. Sessler,et al.  Biodistribution Assessment of a Lutetium(III) Texaphyrin Analogue in Tumor-bearing Mice Using NIR Fourier-transform Raman Spectroscopy¶ , 2004 .

[109]  L. Lilge,et al.  Bioluminescence Imaging of the Response of Rat Gliosarcoma to ALA-PpIX–mediated Photodynamic Therapy¶ , 2004 .

[110]  T. Foster,et al.  Sensitivity of Candida albicans Germ Tubes and Biofilms to Photofrin-Mediated Phototoxicity , 2005, Antimicrobial Agents and Chemotherapy.

[111]  B. Zelickson,et al.  Light Patch: Preliminary Report of a Novel Form of Blue Light Delivery for the Treatment of Actinic Keratosis , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[112]  N. Bressler.  Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease. , 2005, Archives of ophthalmology.

[113]  W. Star,et al.  Construction, quality assurance and calibration of spherical isotropic fibre optic light diffusers , 1995, Lasers in Medical Science.

[114]  Jarod C Finlay,et al.  Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. , 2005, Journal of photochemistry and photobiology. B, Biology.

[115]  Michael S. Patterson,et al.  Calculation of Singlet Oxygen Dose from Photosensitizer Fluorescence and Photobleaching During mTHPC Photodynamic Therapy of MLL Cells¶ , 2005 .

[116]  Lothar Lilge,et al.  Design and performance of thin cylindrical diffusers created in Ge-doped multimode optical fibers. , 2005, Applied optics.

[117]  Avigdor Scherz,et al.  WST11, A Novel Water-soluble Bacteriochlorophyll Derivative; Cellular Uptake, Pharmacokinetics, Biodistribution and Vascular-targeted Photodynamic Activity Using Melanoma Tumors as a Model¶ , 2005, Photochemistry and Photobiology.

[118]  Munawwar Sajjad,et al.  Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible "see and treat" approach. , 2005, Journal of medicinal chemistry.

[119]  S R Arridge,et al.  Recent advances in diffuse optical imaging , 2005, Physics in medicine and biology.

[120]  M S Patterson,et al.  Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid , 2005, British Journal of Cancer.

[121]  B. Nemery,et al.  Cancer nanotechnology: opportunities and challenges. Comment (letter) , 2005 .

[122]  Michael S Patterson,et al.  Calculation of Singlet Oxygen Dose from Photosensitizer Fluorescence and Photobleaching During mTHPC Photodynamic Therapy of MLL Cells ¶ , 2005, Photochemistry and photobiology.

[123]  Arjun G. Yodh,et al.  Noninvasive Monitoring of Murine Tumor Blood Flow During and After Photodynamic Therapy Provides Early Assessment of Therapeutic Efficacy , 2005, Clinical Cancer Research.

[124]  Brian C. Wilson,et al.  Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities. , 2005 .

[125]  Robert R. Alfano,et al.  Fractal Mechanisms of Light Scattering in Biological Tissue and Cells , 2005 .

[126]  Kai Zhang,et al.  Techniques for delivery and monitoring of TOOKAD(WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities , 2005, SPIE BiOS.

[127]  M. Blumenkranz,et al.  Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. , 2002 .

[128]  Kenneth P.H. Pritzker,et al.  Efficiency of singlet oxygen production from self-assembled nanospheres of molecular micelle-like photosensitizers FC4S , 2005 .

[129]  Zheng Huang,et al.  Studies of a vascular‐acting photosensitizer, Pd‐bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer , 2005, Lasers in surgery and medicine.

[130]  B. Wilson,et al.  The propagation of optical radiation in tissue I. Models of radiation transport and their application , 1991, Lasers in Medical Science.

[131]  Michael S Patterson,et al.  Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro , 2005, Physics in medicine and biology.

[132]  Stefan Andersson-Engels,et al.  Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements. , 2005, Applied optics.

[133]  M. Roos,et al.  Changes in vascularity and blood volume as a result of photodynamic therapy can be assessed with power Doppler ultrasonography , 2006, Lasers in surgery and medicine.

[134]  P. V. D. van de Kerkhof,et al.  A placebo‐controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5‐aminolaevulinic acid‐photodynamic therapy in patients with psoriasis , 2006, The British journal of dermatology.

[135]  M. Gold.  Acne and PDT: new techniques with lasers and light sources , 2007, Lasers in Medical Science.

[136]  M. Biel.  Advances in photodynamic therapy for the treatment of head and neck cancers , 2006, Lasers in surgery and medicine.

[137]  Tayyaba Hasan,et al.  Pretreatment photosensitizer dosimetry reduces variation in tumor response. , 2006, International journal of radiation oncology, biology, physics.

[138]  B. Wilson.  PHOTONIC AND NON-PHOTONIC BASED NANOPARTICLES IN CANCER IMAGING AND THERAPEUTICS , 2006 .

[139]  J. Carruthers,et al.  The use of photodynamic therapy in dermatology: results of a consensus conference. , 2006, Journal of drugs in dermatology : JDD.

[140]  Photon-based nanoscience and nanobiotechnology , 2006 .

[141]  Tim Maisch,et al.  Anti-microbial photodynamic therapy: useful in the future? , 2007, Lasers in Medical Science.

[142]  Susumu Terakawa,et al.  Monitoring of Singlet Oxygen Is Useful for Predicting the Photodynamic Effects in the Treatment for Experimental Glioma , 2006, Clinical Cancer Research.

[143]  T. Busch,et al.  Local physiological changes during photodynamic therapy , 2006, Lasers in surgery and medicine.

[144]  J. Usuda,et al.  Photodynamic therapy (PDT) for lung cancers. , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[145]  S B Malkowicz,et al.  Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer , 2006, Lasers in surgery and medicine.

[146]  J. V. van Lier,et al.  Two-photon absorption of copper tetrasulfophthalocyanine induces phototoxicity towards Jurkat cells in vitro , 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[147]  Henricus J C M Sterenborg,et al.  The importance of in situ dosimetry during photodynamic therapy of Barrett's esophagus. , 2006, Gastrointestinal endoscopy.

[148]  M. Patterson,et al.  Application of the modified spherical harmonics method to some problems in biomedical optics , 2006, Physics in medicine and biology.

[149]  Theresa M Busch,et al.  Fluence rate as a modulator of PDT mechanisms , 2006, Lasers in surgery and medicine.

[150]  B. Funke,et al.  Transdermal photodynamic therapy—a treatment option for rheumatic destruction of small joints? , 2006, Lasers in surgery and medicine.

[151]  Mikhail Drobizhev,et al.  Synthesis, characterization, and preclinical studies of two-photon-activated targeted PDT therapeutic triads , 2006, SPIE BiOS.

[152]  Jarod C Finlay,et al.  Real-time In Situ Monitoring of Human Prostate Photodynamic Therapy with Diffuse Light , 2006, Photochemistry and photobiology.

[153]  Henricus J C M Sterenborg,et al.  Protoporphyrin IX Fluorescence Photobleaching and the Response of Rat Barrett's Esophagus Following 5-aminolevulinic Acid Photodynamic Therapy , 2006, Photochemistry and photobiology.

[154]  L. Lilge,et al.  Towards conformal light delivery using tailored cylindrical diffusers: attainable light dose distributions , 2006, Physics in medicine and biology.

[155]  D. Rogers.  Fifty years of Monte Carlo simulations for medical physics , 2006, Physics in medicine and biology.

[156]  Michael S Patterson,et al.  Singlet Oxygen Luminescence Dosimetry (SOLD) for Photodynamic Therapy: Current Status, Challenges and Future Prospects , 2006, Photochemistry and photobiology.

[157]  E. Tschen,et al.  Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12‐month follow up , 2006, The British journal of dermatology.

[158]  Hans C. Fischer,et al.  Pharmacokinetics of Nanoscale Quantum Dots: In Vivo Distribution, Sequestration, and Clearance in the Rat , 2006 .

[159]  S. Stylli,et al.  Photodynamic therapy of cerebral glioma – A review Part II – Clinical studies , 2006, Journal of Clinical Neuroscience.

[160]  Michael S Patterson,et al.  Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions , 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[161]  Smita Dayal,et al.  Quantum Dot-based Energy Transfer: Perspectives and Potential for Applications in Photodynamic Therapy , 2006, Photochemistry and photobiology.

[162]  M. Fujii,et al.  Silicon Nanocrystals: Photosensitizers for Oxygen Molecules , 2005 .

[163]  W. Sibbett,et al.  Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy , 2006, The British journal of dermatology.

[164]  Martijn de Bruin,et al.  Doppler optical coherence tomography to monitor the effect of photodynamic therapy on tissue morphology and perfusion. , 2006, Journal of biomedical optics.

[165]  Daniel B. Shin,et al.  Photofrin Uptake in the Tumor and Normal Tissues of Patients Receiving Intraperitoneal Photodynamic Therapy , 2006, Clinical Cancer Research.

[166]  Positron emission tomography imaging of tumor response after photodynamic therapy. , 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[167]  B. Wilson,et al.  Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation , 2007, Proceedings of the National Academy of Sciences.

[168]  Oliver Sartor,et al.  Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. , 2007, The Journal of urology.

[169]  Wiley Interscience,et al.  Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: Phantom and volunteer experiments , 2007, Lasers in surgery and medicine.

[170]  A. Leunig,et al.  Interstitial photodynamic therapy for a symptom‐targeted treatment of complex vascular malformations in the head and neck region , 2007, Lasers in surgery and medicine.

[171]  Victor X D Yang,et al.  Doppler optical coherence tomography monitoring of microvascular tissue response during photodynamic therapy in an animal model of Barrett's esophagus. , 2007, Gastrointestinal endoscopy.

[172]  Michael R Hamblin,et al.  A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens , 2007, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[173]  J. E. Lier,et al.  Photodynamic inhibition of acetylcholinesterase after two-photon excitation of copper tetrasulfophthalocyanine , 2007, Lasers in Medical Science.

[174]  Mamta Khurana,et al.  Quantitative In Vitro Demonstration of Two‐Photon Photodynamic Therapy Using Photofrin® and Visudyne® , 2007, Photochemistry and photobiology.

[175]  B. Wilson,et al.  Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration. , 2007, Journal of biomedical optics.

[176]  Ken Kang-Hsin Wang,et al.  A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy. , 2006, Medical physics.

[177]  Robert A Weersink,et al.  Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide. , 2007, Radiology.

[178]  S. Hahn,et al.  Intraperitoneal photodynamic therapy. , 2007, Cancer treatment and research.

[179]  Gang Zheng,et al.  Killer beacons for combined cancer imaging and therapy. , 2007, Current medicinal chemistry.

[180]  Adrian Mariampillai,et al.  Interstitial Doppler optical coherence tomography monitors microvascular changes during photodynamic therapy in a Dunning prostate model under varying treatment conditions. , 2007, Journal of biomedical optics.

[181]  Johannes Swartling,et al.  Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate. , 2007, Medical physics.

[182]  B. Overholt,et al.  Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. , 2007, Gastrointestinal endoscopy.

[183]  Colin J R Sheppard,et al.  Fractal model of light scattering in biological tissue and cells. , 2007, Optics letters.

[184]  S. Mennel,et al.  Ocular Photodynamic Therapy – Standard Applications and New Indications (Part 1) , 2007, Ophthalmologica.

[185]  A. Evans,et al.  Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. , 2007, The Journal of urology.

[186]  L. Lilge,et al.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.

[187]  Sari Fien,et al.  Photodynamic therapy for non-melanoma skin cancer. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[188]  H. Sterenborg,et al.  Fractionated aminolevulinic acid–photodynamic therapy provides additional evidence for the use of PDT for non‐melanoma skin cancer , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.